Commercial Considerations for the Development of an Antitheilerial Product

  • F. G. Hooke
Part of the Current Topics in Veterinary Medicine and Animal Science book series (CTVM, volume 14)


The development of a modern anti-protozoal product from discovery to market is an increasingly difficult, expensive, but always interesting project for pharmaceutical companies and their cooperators. Regulatory authorities in the home country of the manufacturer and in the target market together with the increasingly sensitive corporate conscience have ensured the evolution of a development network of growing complexity and cost. There are additional constraints imposed on sales and distribution of the final products in some target markets which all combine to ensure a more cautious approach to development of promising discovery compounds and inevitably slower and more expensive research by fewer companies. This paper will attempt to address some of these issues.


Host Country Target Market Target Animal Equivalent Dose Rate East African Community 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Martinus Nijhoff Publishers, The Hague, Boston, London 1981

Authors and Affiliations

  • F. G. Hooke

There are no affiliations available

Personalised recommendations